TME Pharma N.V. announces private placement of 6,727,270 ordinary shares at an issue price of ?0.22 per share for gross proceeds of ?1,479,999.4 on February 9, 2024. The transaction is expected to close on February 12, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.249 EUR | +0.20% | -0.99% | +8.26% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.26% | 7.56M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALTME Stock
- News TME Pharma N.V.
- TME Pharma N.V. announced that it expects to receive ?1.479999 million in funding